These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Laboratory evaluation of face paint repellent formulation using human volunteers under three climatic regimens. Gupta RK; Rutledge LC; Frommer RL J Med Entomol; 1989 Sep; 26(5):468-70. PubMed ID: 2795618 [TBL] [Abstract][Full Text] [Related]
66. Comparative study of the topical effectiveness of the Andiroba oil (Carapa guianensis) and DEET 50% as repellent for Aedes sp. Miot HA; Batistella RF; Batista Kde A; Volpato DE; Augusto LS; Madeira NG; Haddad V; Miot LD Rev Inst Med Trop Sao Paulo; 2004; 46(5):253-6. PubMed ID: 15517027 [TBL] [Abstract][Full Text] [Related]
68. Structure-activity relationship studies on the mosquito toxicity and biting deterrency of callicarpenal derivatives. Cantrell CL; Klun JA; Pridgeon J; Becnel J; Green S; Fronczek FR Chem Biodivers; 2009 Apr; 6(4):447-58. PubMed ID: 19353538 [TBL] [Abstract][Full Text] [Related]
69. Repellency of aromatic medicinal plant extracts and a steam distillate to Aedes aegypti. Yang YC; Lee EH; Lee HS; Lee DK; Ahn YJ J Am Mosq Control Assoc; 2004 Jun; 20(2):146-9. PubMed ID: 15264623 [TBL] [Abstract][Full Text] [Related]
70. Some corrections to the record on insect repellents and attractants. Rutledge LC J Am Mosq Control Assoc; 1988 Dec; 4(4):414-25. PubMed ID: 3066844 [TBL] [Abstract][Full Text] [Related]
71. A new in vitro bioassay system for discovery of novel human-use mosquito repellents. Klun JA; Kramer M; Debboun M J Am Mosq Control Assoc; 2005 Mar; 21(1):64-70. PubMed ID: 15825764 [TBL] [Abstract][Full Text] [Related]
72. Efficacy of the main repellents available in the Brazilian market against Aedes aegypti bites under concentrations applied to pediatric populations. Silva BOD; Olivatti TOF; Kanda RG; Marco GN; Santaella FJ; Madeira NG; Haddad Junior V; Miot HA Rev Soc Bras Med Trop; 2018; 51(2):256-257. PubMed ID: 29768569 [No Abstract] [Full Text] [Related]
73. Why the mosquito bites: a tale of blood, sweat and tears. Maibach H; Strauss W; Skinner WA N Engl J Med; 1970 Jan; 282(5):279. PubMed ID: 4391319 [No Abstract] [Full Text] [Related]
74. Advancing the science of EPA guidelines for sponsor-financed topical insect repellent efficacy studies. Young LJ; Fisher CB Regul Toxicol Pharmacol; 2010 Feb; 56(1):51-3. PubMed ID: 19914325 [TBL] [Abstract][Full Text] [Related]
77. [Crotamiton (Eurax) as a mosquito repellent]. Granhus B; Sandvik L; Eid AB Tidsskr Nor Laegeforen; 1986 Jun; 106(16):1406-7. PubMed ID: 2875545 [No Abstract] [Full Text] [Related]
78. Vitamin B1 is not a systemic mosquito repellent in man. Khan AA; Maibach HI; Strauss WG; Fenley WR Trans St Johns Hosp Dermatol Soc; 1969; 55(1):99-102. PubMed ID: 4389912 [No Abstract] [Full Text] [Related]
79. [Resistance of insect repellents to washing off with water after their application to cloth and skin (laboratory tests)]. Potapov AA; Zharova AN; Vladimirova VV; Kornienko NI Med Parazitol (Mosk); 1978; 47(1):81-5. PubMed ID: 651800 [No Abstract] [Full Text] [Related]
80. Chemical defense against blood-feeding arthropods by disruption of biting behavior. Debboun M; Klun JA US Army Med Dep J; 2008; ():4-8. PubMed ID: 20084728 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]